LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Product Launch CorMedix's recent commercialization of DefenCath in both inpatient and outpatient healthcare settings presents a significant sales opportunity for medical suppliers, distributors, and service providers specializing in infection control, catheter management, and healthcare-associated infection prevention.

Strategic Acquisition Expansion The company's $300 million acquisition of Melinta Therapeutics deepens its portfolio in infectious disease therapeutics, opening avenues to collaborate with hospitals, clinics, and institutions seeking comprehensive solutions for infectious disease management.

Financial Growth Signals With reported revenues between $100M and $250M and recent investor confidence demonstrated by a $85M funding round, CorMedix is positioned for expansion. Engaging with supply chain partners and healthcare providers could tap into this growth trajectory.

Regulatory Milestones CorMedix's DefenCath has received FDA Fast Track and QIDP designations, indicating strong market validation and unmet medical needs, which can be leveraged to develop targeted sales campaigns towards hospitals and outpatient clinics prioritizing innovative infection prevention solutions.

Industry Engagement Participation in major healthcare conferences like Needham Virtual Healthcare events provides opportunities for direct outreach, networking, and positioning product offerings to key industry stakeholders and decision-makers in pharmaceutical and healthcare sectors.

Cormedix Inc. Tech Stack

Cormedix Inc. uses 8 technology products and services including cdnjs, Cloudflare, oEmbed, and more. Explore Cormedix Inc.'s tech stack below.

  • cdnjs
    Content Delivery Network
  • Cloudflare
    Content Management System
  • oEmbed
    Dev Tools
  • Shopify
    E-commerce
  • jQuery
    Javascript Libraries
  • Flywheel
    Platform As A Service
  • X-XSS-Protection
    Security
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Cormedix Inc.'s Email Address Formats

Cormedix Inc. uses at least 1 format(s):
Cormedix Inc. Email FormatsExamplePercentage
FLast@cormedix.comJDoe@cormedix.com
98%
FirstLast@cormedix.comJohnDoe@cormedix.com
1%
First_Last@cormedix.comJohn_Doe@cormedix.com
1%

Frequently Asked Questions

Where is Cormedix Inc.'s headquarters located?

Minus sign iconPlus sign iconCormedix Inc.'s main headquarters is located at 300 Connell Drive Suite 4200 Berkeley Heights, New Jersey 07922 United States. The company has employees across 3 continents, including North AmericaAsiaSouth America.

What is Cormedix Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Cormedix Inc.'s main corporate office by phone at
+1-908-517-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cormedix Inc.'s stock symbol?

Minus sign iconPlus sign iconCormedix Inc. is a publicly traded company; the company's stock symbol is CRMD.

What is Cormedix Inc.'s official website and social media links?

Minus sign iconPlus sign iconCormedix Inc.'s official website is cormedix.com and has social profiles on LinkedInCrunchbase.

How much revenue does Cormedix Inc. generate?

Minus sign iconPlus sign icon As of April 2026, Cormedix Inc.'s annual revenue is estimated to be $7.6M.

What is Cormedix Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconCormedix Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cormedix Inc. have currently?

Minus sign iconPlus sign iconAs of April 2026, Cormedix Inc. has approximately 185 employees across 3 continents, including North AmericaAsiaSouth America. Key team members include Chief Commercial Officer (cco): M. S.Chief Clinical Strategy & Operations Officer: L. H.Chief Manufacturing Officer: T. M.. Explore Cormedix Inc.'s employee directory with LeadIQ.

What industry does Cormedix Inc. belong to?

Minus sign iconPlus sign iconCormedix Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Cormedix Inc. use?

Minus sign iconPlus sign iconCormedix Inc.'s tech stack includes cdnjsCloudflareoEmbedShopifyjQueryFlywheelX-XSS-ProtectionX-Content-Type-Options.

What is Cormedix Inc.'s email format?

Minus sign iconPlus sign iconCormedix Inc.'s email format typically follows the pattern of FLast@cormedix.com. Find more Cormedix Inc. email formats with LeadIQ.

How much funding has Cormedix Inc. raised to date?

Minus sign iconPlus sign icon As of April 2026, Cormedix Inc. has raised $85M in funding. The last funding round occurred on Jun 26, 2025 for $85M.

When was Cormedix Inc. founded?

Minus sign iconPlus sign iconCormedix Inc. was founded in 2006.

Cormedix Inc.

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. 

The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need.  

For more information, visit: www.cormedix.com.

Section iconCompany Overview

Headquarters
300 Connell Drive Suite 4200 Berkeley Heights, New Jersey 07922 United States
Phone number
+1-908-517-****
Website
cormedix.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
CRMD
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2006
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $85M

    Cormedix Inc. has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Jun 26, 2025 in the amount of $85M.

  • $100M$250M

    Cormedix Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $85M

    Cormedix Inc. has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Jun 26, 2025 in the amount of $85M.

  • $100M$250M

    Cormedix Inc.'s revenue is estimated to be in the range of $100M$250M

Company Leadership

  • Stylized image of a person
    M. S.
    Chief Commercial Officer (cco)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. H.
    Chief Clinical Strategy & Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. M.
    Chief Manufacturing Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. B.
    Chief Accounting Officer (cao)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. L.
    Chief Financial Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    L. H.
    Chief Clinical Strategy & Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. H.
    Senior Executive Assistant To Chairman & Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. M.
    Chief Manufacturing Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. B.
    Chief Accounting Officer (cao)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. L.
    Chief Financial Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.